Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries-Reference-Cited by-同舟云学术

Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries

Published:2024-03 Issue: Volume:38 Page:100838
ISSN:2666-7762
Container-title:The Lancet Regional Health - Europe
language:en
Short-container-title:The Lancet Regional Health - Europe

Author:

de Jager Vincent D.,Timens Wim^ORCID,Bayle Arnaud,Botling Johan,Brcic Luka^ORCID,Büttner Reinhard,Fernandes Maria Gabriela O.,Havel Libor,Hochmair Maximilian J.,Hofman Paul,Janssens Annelies,Johansson Mikael,van Kempen Léon^ORCID,Kern Izidor,Lopez-Rios Fernando,Lüchtenborg Margreet,Machado José Carlos,Mohorcic Katja,Paz-Ares Luis,Popat Sanjay,Ryška Aleš^ORCID,Taniere Phillipe,Wolf Jürgen,Schuuring Ed,van der Wekken Anthonie J.

Publisher

Elsevier BV

Reference87 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. European cancer mortality predictions for the year 2023 with focus on lung cancer;Malvezzi;Ann Oncol,2023

3. Lung cancer staging: state of the art in the era of ablative therapies and surgical segmentectomy;Gregor;Respirology,2020

4. The effect of advances in lung-cancer treatment on population mortality;Howlader;N Engl J Med,2020

5. Oncogene-addicted metastatic non-small-cell lung cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up;Hendriks;Ann Oncol,2023

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Exhaled Breath Condensate in Chronic Inflammatory and Neoplastic Diseases of the Respiratory Tract;International Journal of Molecular Sciences;2024-07-05

2. Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands;European Journal of Cancer;2024-07

3. The rapidly changing field of predictive biomarkers of non-small cell lung cancer;Pathology and Oncology Research;2024-06-17

4. Biomarker testing in patients with advanced non-small cell lung cancer: the never-ending story;The Lancet Regional Health - Europe;2024-03

5. Future perspective for the application of predictive biomarker testing in advanced stage non-small cell lung cancer;The Lancet Regional Health - Europe;2024-03